Genenta Science

Biotechnology
Genenta Science SPA is a clinical-stage biotechnology company engaged in the development of hematopoietic stem cell gene therapies for the treatment of solid tumors and cancer. The company's products include Temferon - a product to treat glioblastoma multiforme, a solid tumor affecting the brain.

$69.5M

Market Cap • 7/4/2025

2014

(11 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of IT

Milan

Headquarters